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Abstract: The reported relationships between nerve conduction
studies (NCS) and outcome measures in carpal tunnel syndrome
(CTS) are weak to moderate. However, selection of patients may
have confounded nonrandomized studies. NCS have potentially
great value in selecting patients for a specific treatment and in
objectively assessing the efficacy of treatments in CTS, especially if
they correlate significantly with clinical outcome measures. To
investigate the relationship between clinical outcome measures for
the severity of complaints and NCS in patients treated for CTS, data
were obtained from a multicenter randomized controlled trial on the
efficacy of splinting versus surgery for CTS. At baseline and 12
months after randomization, clinical outcome measures were as-
sessed and NCS were performed. In total, 138 patients completed
the questionnaires and underwent repeated NCS. Relationships were
analyzed with Spearman rank correlation coefficients and Pearson
correlation coefficients. All NCS parameters showed highly signif-
icant improvement compared with baseline (P  0.001). Modest
correlations (0.4) were found between the neurophysiologic and
clinical outcome measures after 12 months, and between the changes
in these different categories of outcome measures. This study con-
firms that the parameters of NCS improve significantly after treat-
ment for CTS, but the modest correlations between neurophysio-
logic and clinical outcome measures do not support that NCS are
routinely performed in clinical practice to evaluate treatment effects.
However, studies investigating the effects of treatment for CTS
should incorporate both clinical outcome measures and NCS, be-
cause they are complementary. Furthermore, NCS can provide
additional information to the clinician when treatment effects are
unsatisfactory.
Key Words: Carpal tunnel syndrome, Treatment outcome, Nerve
conduction studies.
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Nerve conduction studies (NCS) are frequently used to con-
firm the clinical diagnosis of carpal tunnel syndrome (CTS),
and as outcome measures in clinical trials (Ebenbichler et al.,
1998; Gerritsen et al., 2002; Hoefnagels et al., 1997). How-
ever, the actual correlations between NCS and clinical out-
come measures (such as severity scales and questionnaires)
are weak to moderate (Dhong et al., 2000; You et al., 1999).
This discrepancy, or “clinical-neurophysiologic paradox,” is
reflected in the ongoing discussion whether clinical or neu-
rophysiological parameters must be used as the “gold stan-
dard” for the diagnosis of CTS. All clinicians who regularly
see patients with CTS have come across those with typical
and sometimes severe complaints, but normal or marginally
abnormal NCS. However, it has been shown that the results
of NCS in asymptomatic individuals can be abnormal (Atro-
shi et al., 1999).
Despite these obvious inconsistencies, NCS undoubt-
edly have merits. They can demonstrate objective evidence of
nerve dysfunction and may aid in the selection of patients for
a specific treatment, especially if there is a reasonable corre-
lation between pretreatment results of NCS and clinical
outcome.
Because the symptoms and difficulties in performing
daily activities determine why patients seek treatment and
how they judge the effects of treatment, outcome measures
should reflect these aspects. Both clinical and neurophysio-
logic outcome measures have been proposed, but these differ
in their stronger and weaker points. Although patients with
similar complaints may have different scores on self-admin-
istered questionnaires such as the Symptom Severity Scale
and the Functional Status Scale, the intrarater reliability is
high (Atroshi et al., 1998; Levine et al., 1993). However,
self-administered questionnaires are more susceptible to con-
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founding by subjective information provided by the patients
than the objective data collected in NCS. However, the results
of NCS may also vary over time and between performers
because of environmental factors (e.g., temperature) and
technical skills or equipment (Bleasel and Tuck 1991;
Chaudhry et al., 1991; Kimura, 1997).
Most clinicians consider the relief of symptoms and
improvement of functional status to be the most important
determinants of a treatment’s success. Hence, for NCS to play
a role in the outcome assessment, it is important that the
results of NCS correlate strongly with clinical outcome mea-
sures. Several studies have addressed this question, and have
reported weak correlations (0.5) between the results of
NCS and symptoms or functional status (Dhong et al., 2000;
Levine et al., 1993; You et al., 1999).
In a prospective study evaluating the effects of surgi-
cally treated CTS, the usefulness of the self-administered
Boston Questionnaire (BQ) in qualifying severity of symp-
toms and functional state of patients before surgery, and also
in showing improvement after surgery, was confirmed. How-
ever, it was not possible to predict the patient-oriented results
of the operation from the presurgical BQ score. In contrast,
the degree of improvement in sensory and motor distal
conduction velocities could be forecast from presurgical val-
ues. Still, no significant correlations were found between the
degree of improvement in the symptom severity or functional
status scores and the nerve conduction values (Mondelli et al.,
2000). The authors suggested that both methods should be
used together because they are complementary.
Another prospective study reported a significant rela-
tionship between clinical improvement and improvement in
sensory nerve conduction velocity (SNCV) after surgery
(Dudley Porras et al., 2000). In fact, the study did not assess
the actual correlations between the improvement in SNCV
and the clinical improvement as measured by questionnaire,
but only documented the improvement in SNCV after sur-
gery. No relationship was found between the results of the
preoperative electromyographic studies and the preoperative
clinical symptom and functional status scores, and there were
several patients who had major symptoms and minimal
changes on electrodiagnostic tests, and vice versa. Hence, the
conclusions made by the authors that the SNCV has a
significant relationship with clinical improvement, and that it
is an objective way of measuring postoperative outcome and
the patient’s ability to return to their activities, are not
substantiated by the evidence presented.
Because none of the aforementioned studies random-
ized patients to treatment, the results may have been influ-
enced by the selection of patients on clinical and/or neuro-
physiologic grounds.
The objective of our study was to investigate whether
the results of NCS correlate with clinical outcome measures
or changes thereof in patients participating in a randomized
controlled trial on the efficacy of splinting versus surgery.
MATERIALS AND METHODS
The data for this study were obtained from a multi-
center randomized controlled trial comparing the efficacy of
splinting and surgery for the relief of CTS symptoms (Ger-
ritsen et al., 2002).
Study Population
Patients were selected by neurologists in 13 participat-
ing hospitals. To be included in the trial, patients had to meet
the following criteria: (1) pain, paraesthesia, and/or hypoes-
thesia in the hand, in the area innervated by the median nerve;
(2) confirmation of the clinical diagnosis by NCS, the meth-
ods of which are described below; (3) aged 18 years or older;
(4) ability to complete written questionnaires (in Dutch); (5)
not previously treated with splinting or surgery; (6) no history
of wrist trauma (e.g., fracture) or surgery; (7) no history
suggesting underlying causes of CTS (e.g., diabetes mellitus,
pregnancy); (8) no clinical signs or symptoms, or findings in
NCS, suggesting conditions that could mimic CTS or inter-
fere with its validation (e.g., cervical radiculopathy, polyneu-
ropathy); and (9) no severe thenar muscle atrophy. The
eligibility of patients was checked again by one of the
research physiotherapists in the hospital concerned. After
patients had given written informed consent and the baseline
assessment had been performed, they were randomly allo-
cated to either wrist splinting during the night for at least 6
weeks, or open carpal tunnel release.
Nerve Conduction Studies
According to the guidelines of the (American Associ-
ation of Electrodiagnostic Medicine, 1993), the following
protocol was adopted (Ross and Kimura, 1995). Skin tem-
perature was measured before testing, and hands with a
temperature of less than 32°C were warmed (Denys, 1991).
Both hands were tested. Sensory and motor nerve conduction
was studied, using surface electrodes for stimulating and
recording. Latencies were measured from the stimulus onset
to the initial negative response, and amplitudes were mea-
sured from baseline to negative peak. The sensory nerve
action potentials were recorded antidromically, with ring
electrodes around the proximal (active) and distal (reference)
interphalangeal joints. The ground electrode was attached to
the distal region of the wrist. Median SNCV was measured
from the wrist to the index and ring fingers. Ulnar nerve
sensory conduction was measured from the wrist to the ring
finger. The distances between the median and ulnar stimula-
tion sides at the wrist and the recording electrodes on the ring
finger were equal. The compound muscle action potential was
recorded from the thenar eminence, with the active recording
electrode placed over the abductor pollicis brevis muscle
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belly. The reference electrode was placed over the abductor
pollicis brevis tendon. Median nerve distal motor latency was
measured with stimulating and recording cathodes 7 cm
apart. Median motor nerve conduction velocity was measured
in the forearm. Supramaximal stimulation was delivered to
the elbow and wrist.
The criteria used to confirm the clinical diagnosis of
CTS were: (1) SNCV (index finger)  41.9 m/second in
patients younger than 55 years or37.3 m/second in patients
55 years or older, or distal sensory latency (DSL) (index
finger)  3.5 milliseconds (Kimura, 1979), or (2) median-
ulnar DSL difference (ring finger)  0.4 milliseconds
(Charles et al., 1990), or (3) distal motor latency  4.34
milliseconds (Kimura, 1979).
Outcome Assessment
In the randomized controlled trial a distinction was
made, a priori, between primary and secondary outcome
measures. The primary outcome measures were considered to
be the most relevant for both the patients and the clinicians.
At baseline and 12 months after randomization, the
patients visited the hospital and completed written question-
naires. The following (primary) outcome measures for sever-
ity of complaints were used: (1) the number of nights that the
patient awoke due to the symptoms during the past week; (2)
the severity of the main complaint, pain, and paraesthesia at
night and during the day during the past week, scored by the
patient on an 11-point numerical rating scale, ranging from 0
(“no symptoms”) to 10 (“very severe symptoms”) (van der
Windt et al., 1998); and (3) the mean score on the Symptom
Severity Scale (11 questions about symptoms experienced
during the past 2 weeks; 1  mildest, 5  most severe) and
the Functional Status Scale (eight items concerning difficul-
ties in performing various activities of daily living during the
past 2 weeks; 1  no difficulty, 5  cannot perform activity
at all) (Levine et al., 1993).
The NCS were repeated 12 months after randomization.
The following nerve conduction parameters were used as
(secondary) outcome measures: SNCV (index finger) (meters
per second); DSL (index finger) (milliseconds); median-ulnar
DSL difference (ring finger) (milliseconds); and distal motor
latency (milliseconds).
Statistical Analysis
The relationships between the actual values of the
different nerve conduction parameters and the different out-
come measures for complaints 12 months after randomization
were assessed with Spearman rank correlation coefficients,
because the scores on the outcome measures for complaints
did not follow a normal distribution. For both the nerve
conduction parameters and the outcome measures for severity
of complaints, change scores (difference between baseline
and follow-up) were calculated for each patient separately.
Subsequently, the relationships between the changes in the
different nerve conduction parameters and the changes in the
different outcome measures for complaints were assessed
with Pearson correlation coefficients, because the change
scores closely followed a normal distribution. A strong cor-
relation was arbitrarily defined as 0.7 or higher.
RESULTS
Study Population
A total of 176 patients were included in the trial. Table
1 shows the baseline characteristics of the study population.
A total of 156 patients completed the questionnaires 12
months after randomization, and 138 of them also underwent
the repeated NCS. Of the 18 patients who did not undergo the
repeated NCS but who completed the questionnaires at home,
13 simply did not wish to visit the hospital again, and five
explicitly refused to undergo NCS again because they had
found it too painful the first time. There were some missing
values for the nerve conduction parameters at baseline and
follow-up, either because these parameters had not been
measured or because there was no sensory or motor response
that could be measured.
Correlation Between Neurophysiological and
Clinical Outcome Measures
Table 2 shows the values of the outcome measures for the
severity of complaints and the nerve conduction parameters at
baseline and 12 months after randomization. The changes in
outcome measures between baseline and follow-up are also
presented. All NCS and clinical outcome parameters improved
significantly compared with baseline (P  0.001).
In Table 3, the Spearman rank correlation coefficients
are presented for the relationships between the values of the
different nerve conduction parameters and the different out-
come measures for complaints 12 months after randomiza-
tion. Only modest correlations were found (range 0.01 to
0.33). The strongest correlations were found between the
“number of nights waking up due to symptoms” and the
TABLE 1. Demographic Characteristics of the Study
Population
Number of Patients 176
Age in years (mean, SD) 49 (11)
Female/male (%) 143 (81)/33 (19)
Duration of complaints (weeks)* 52 (23,104)
Bilateral complaints (%) 104 (59)
Dominant side most affected (%) 116 (66)
Previous episode of CTS complaints (%) 53 (30)
SD, standard deviation.
*Median and interquartile range.
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“median-ulnar DSL difference” 12 months after randomiza-
tion (Spearman rank correlation coefficient 0.33, P  0.001)
and between “paraesthesia at night” and the “median-ulnar
DSL difference” 12 months after randomization (Spearman
rank correlation coefficient 0.32, P  0.001).
In addition, Pearson correlation coefficients between
the changes in the nerve conduction parameters and the
changes in the outcome measures for complaints were calcu-
lated, and similar weak correlations (range 0.00 to 0.26) were
found (data not shown).
DISCUSSION
We investigated the relationship between outcome mea-
sures for the severity of complaints and the results of NCS in
patients treated for CTS in a randomized controlled trial. All
NCS and clinical outcome parameters showed highly significant
improvement compared to baseline. However, only modest
correlations (0.4) were found between the actual values of the
different categories of outcome measures 12 months after ran-
domization and between the changes in the different categories
of outcome measures. Because the data for this study were
obtained from a randomized controlled trial, the patients re-
ceived different types of treatment. However, a separate analysis
of the patients randomized to surgery (n  66) showed corre-
lations within the same range as for all patients (data not shown).
Of the patients allocated to splinting (n  72), 30 (42%) had
undergone surgery at the time of the follow-up measurement 12
months after randomization. Hence, separate analysis of the
TABLE 2. Clinical and Neurophysiological Outcome Measures at Baseline and 12 Months After Randomization
Outcome Measures Baseline
Follow-up
(12 months)
Change ¶
(Baseline and
Follow-up)
Severity of complaints* Median (interquartile range) Mean (SD)
Nights/week waking up due to symptoms (0–7) 4 (1,7) 0 (0,0) 3.2 (2.9)
Severity main complaint 7 (6,8) 0 (0,1.3) 5.8 (2.9)
Pain (during the day) 4 (0,6) 0 (0,1) 2.9 (3.1)
Pain (at night) 5 (0,8) 0 (0,0) 4.2 (3.5)
Paraesthesia (during the day) 6 (3,8) 0 (0,1) 4.8 (3.2)
Paraesthesia (at night) 6 (3,8) 0 (0,0.3) 5.0 (3.4)
Symptom severity score (1–5) 2.5 (1.8,3.0) 1.1 (1,1.5) 1.1 (0.8)
Functional status score (1–5) 2.1 (1.5,2.9) 1 (1,1.4) 0.9 (0.9)
Nerve conduction parameters
SNCV (index finger, m/s) 37.8 (8.9) 44.2 (7.3) 7.4 (9.6)
DSL (index finger, ms) 4.2 (1.0) 3.5 (0.6) 0.8 (0.9)
Median-ulnar DSL difference (ring finger, ms) 1.7 (1.2) 0.9 (0.7) 0.9 (1.2)
DML (ms) 5.6 (1.7) 4.5 (1.0) 1.1 (1.5)
SD, standard deviation; SNCV, sensory nerve conduction velocity; DSL, distal sensory latency; DML, distal motor latency.
*Range of scores is 0 to 10 (10 indicating severe complaints), unless indicated otherwise.
¶Change between baseline and follow-up for all clinical and NCS outcome measures; P  0.001 (paired samples test).
TABLE 3. Correlations Between Neurophysiological and Clinical Outcome Measures at Follow-up*
Outcome Measures
Nights/Week
(Waking due
to Symptoms)
Severity
(Main
Complaint)
Pain
(Day)
Pain
(Night)
Paraesthesia
(Day)
Paraesthesia
(Night)
Symptom
Severity
Score
Functional
Status
Score
SNCV 0.21 0.12 0.04 0.12 0.19 0.18 0.14 0.07
DSL 0.18 0.14 0.03 0.07 0.15 0.16 0.10 0.01
Median-ulnar DSL
difference
0.33† 0.28 0.11 0.15 0.23 0.32† 0.19 0.02
DML 0.25 0.21 0.10 0.20 0.24 0.28 0.19 0.07
SNCV, sensory nerve conduction velocity; DSL, distal sensory latency; DML, distal motor latency.
*Twelve months after randomization; Spearman rank correlation coefficients.
†P  0.001.
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patients treated solely with splinting (n  42) was performed
and similar modest correlations were found (data not shown).
Our findings regarding these correlations corroborate earlier
observations. In a recent retrospective study in 62 patients who
had undergone carpal tunnel decompression surgery, no rela-
tionship was found between the nature or duration of preopera-
tive symptoms and the severity of the electrophysiologic impair-
ment. Furthermore, no relationship could be identified between
preoperative NCS and the outcome of surgery (Longstaff et al.,
2001). In a prospective study in 43 patients investigating the
predictive value of NCS on clinical outcome after endoscopic
carpal tunnel surgery, all electrophysiologic parameters im-
proved after surgery. It was, however, not possible to predict
failure in clinical improvement or worsening of NCS in individ-
ual cases. Many patients still showing abnormal NCS results
were satisfied with the result of the surgery, whereas others
reporting of serious symptoms had improved or normal NCS
results (Vogt and Scholz, 2002).
However, our observation that all NCS parameters
improved significantly after treatment is in line with a number
of studies that provide evidence in support of clinical and
electrophysiologic relationships. In a large, multicenter study
comprising 1,123 hands, highly significant (P  0.001)
correlations were found between functional impairment
(measured using patient-oriented questionnaires) and NCS,
although the exact correlation coefficients were not reported.
Interestingly, it was demonstrated that the domains “symp-
toms” and “pain” behaved differently than the domain “func-
tion.” Scores for symptoms and pain were higher in patients
with normal NCS than in patients with minimal neurophysi-
ologic impairment, increased progressively in patients with
moderate and severe neurophysiologic impairment, and de-
creased in patients with extreme neurophysiologic impair-
ment (Padua et al., 1999). A low pain and discomfort thresh-
old in the first phase of nerve entrapment that later increases
was postulated to explain these observations. Giannini et al.
(2002) validated a new clinical scale, the historical-objective
(Hi-Ob) scale, and reported a significant correlation (r 
0.42) between the Hi-Ob score and NCS, divided in six
neurophysiologic classes. Correlations with specific domains
(symptoms, function, pain) showed only weak correlations,
with correlation coefficients ranging from 0.17 to 0.28.
What general lessons can be learned from the results of
this randomized controlled trial and those of other studies
regarding the usefulness of NCS in evaluating treatment
effects in patients with CTS? First, there seems to be no
indication to routinely perform NCS in clinical practice to
evaluate the treatment effects in CTS. The correlations ob-
served in this study and in the literature are only modest, and
cannot be used to predict outcome in individual cases. It
remains possible, however, that dividing the results of NCS in
different classes or combining NCS parameters to a sumscore
will yield stronger correlations. Second, it has become clear
that clinical outcome measures derived from validated ques-
tionnaires and NCS are complementary. NCS can demon-
strate objective evidence of nerve dysfunction, whereas pa-
tient-oriented clinical scales are meant to reflect the most
important aspects of the success of treatment from the
patients’point of view. To objectively compare outcome in
various patient series a standardized approach is necessary.
Recently, a protocol for the evaluation of outcome was
proposed that incorporates the BQ, Hi-Ob scale, and NCS
divided in five severity classes. The validity was demon-
strated by applying the protocol prospectively on a series of
323 hands (Reale et al., 2003). Hence, studies investigating
the effects of treatment for CTS should incorporate both
clinical outcome measures and NCS.
Furthermore, NCS can provide additional information
to the clinician when treatment effects are unsatisfactory.
When NCS performed after surgery show improvement de-
spite persisting complaints, it should alert the clinician to the
possibility of a diagnosis other than CTS. However, worsen-
ing NCS should raise the question of whether release of the
transverse ligament has been properly performed, or lead to
the consideration of other disorders with prominent involve-
ment of the median nerve. Various disorders (e.g., radiculop-
athy, motor neuron disease, spondylotic myelopathy, syrin-
gomyelia) can masquerade as CTS, and are sometimes
recognized only after carpal tunnel release has been unsuc-
cessful (Witt and Stevens, 2000).
In conclusion, although NCS cannot be considered
essential in assessing (individual) outcome in CTS, to discard
them completely as an “unnecessary luxury” (Smith, 2002) is
also inappropriate. In assessing outcome, clinicians must
balance between the strength of NCS in providing objective
evidence of nerve dysfunction and their shortcomings. For
scientific purposes, it is recommended that clinical question-
naires and NCS be combined in a standardized approach, to
cover the spectrum of signs and symptoms in CTS.
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